EN
HI
Summary
As of 22 Sep, 2026, Lupin stock price is ₹2135. During the trading session, the stock has moved between an intraday low of ₹2109.00 and an intraday high of ₹2135.00. Over the last 52 weeks, Lupin has traded between ₹1900.00 and ₹2529.50.
The stock has recorded a trading volume of 5,97,568 shares,. Its Average Traded Price (ATP) is ₹2120.19, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 54 @ ₹2135.00.
Lupin has an upper circuit limit of ₹2336.90 and a lower circuit limit of ₹1912.10. The total value traded stands at ₹126.70 CR, and the delivery percentage for the day is 54.35%.
The stock is currently traded with a market lot size of 1. Lupin also offers a dividend yield of 0.85%.
Lupin Share Price Chart
Lupin Share Key Metrics
Volume
5.98 L
Market Cap
97619.15 CR
LTQ@LTP
54@2135.00
ATP
2120.19
Var Margin
12.5 %
Circuit Range
1912.1-2336.9
Delivery %
54.35 %
Value
126.70 CR
ASM/GSM
No
Market Lot
1
Lupin Fundamentals
P/E Ratio
17.53
P/B Ratio
4.07
Div. Yield
0.85
Sector P/E
37.95
Sector P/B
3.67
Sec. Div. Yield
0.51
Lupin Resistance and Support
Pivot 2111.17
Resistance
First Resistance
2142.34
Second Resistance
2160.17
Third Resistance
2191.34
Support
First Support
2093.34
Second Support
2062.17
Third Support
2044.34
Lupin Futures & Options
Lupin Option Chain
View Price, OI, Greeks & More...
29SEP26
2118.00
-4.10 (0.19%)
27OCT26
2128.10
-5.50 (0.26%)
23NOV26
2136.50
-8.40 (0.39%)
LUPIN|29SEP26 CE 2120.00
19.70
-3.8 (-16.17%)
LUPIN|29SEP26 PE 2140.00
33.1
-1 (-2.93%)
Lupin Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Sep 22 2026 | 2123.6 | 2135 | 0.49% | 2135 | 2109 |
| Mon Sep 21 2026 | 2084 | 2124.5 | 1.99% | 2129 | 2080 |
| Fri Sep 18 2026 | 2088.1 | 2083 | -0.72% | 2114.69 | 2075 |
Lupin Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Lupin News
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Lupin is scheduled to participate in two analyst/institutional investor meets in September 2026. The company will attend the Kotak Healthcare Conference on Sept 17 and the J.P. Morgan India Conference on Sept 21. Presentations will be available on company/stock exchange websites.
Sep 08 2026 16:38:56
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin has secured U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP. This approval covers both 100 mg and 200 mg strengths, addressing excessive sleepiness conditions like narcolepsy and obstructive sleep apnea. The reference drug had US annual sales of $70.7 million.
Sep 04 2026 17:42:17
Read More
Lupin Management
| Name | Position |
|---|---|
| Manju D Gupta | Chairperson |
| Nilesh Gupta | Managing Director |
Lupin Similar Stocks
Zydus Lifesciences Ltd.
1162.30
1.30 (0.11%)
Cipla Ltd.
1384.10
-2.00 (0.14%)
Laurus Labs Ltd.
2006.50
-11.00 (0.55%)
Max Healthcare Institute Ltd.
1056.50
-10.10 (0.95%)
Aurobindo Pharma Ltd.
1700.00
-13.40 (0.78%)
Dr. Reddy's Laboratories Ltd.
1211.00
12.70 (1.06%)
Manipal Health Enterprises Ltd.
746.10
-1.05 (0.14%)
Mankind Pharma Ltd.
2480.00
42.20 (1.73%)
Glenmark Pharmaceuticals Ltd.
2461.40
11.40 (0.47%)
Fortis Healthcare Ltd.
896.55
3.05 (0.34%)
Lupin FAQs
The Buying Price of Lupin share is 2135 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lupin stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lupin, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lupin shares is 17.53. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lupin shares is 4.07. Useful to assess the stock's value relative to its book value.
To assess Lupin’s valuation compare Sector P/E, P/B which are 37.95 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lupin is 97619.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lupin share price is 2529.50 & 1900.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lupin belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in LUPIN
